Description:
Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinase inhibitor of CSF-1R with IC50 of 20 nM, Kit with IC50 of 10 nM, and Flt3 with IC50 160 nM. Phase 3, respectively.
- Molecular Weight:417.81
- Purity:98%
Molecular Formula:
C20H15ClF3N5
Canonical SMILES:
FC(C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C43)C=C2)C=N1)(F)F
Solubility:
Soluble in DMSO, not in water
Appearance:
Yellow solid powder
Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Synonyms:
PLX3397; PLX-3397; PLX 3397; Pexidartinib Weitere Informationen finden Sie
hier